Head injury and risk of Alzheimer's disease by apolipoprotein E genotype

American Journal of Epidemiology

Volumn 146, Issue 5, 1997, Pages 373-384

  O'Meara, Ellen S ^a   Kukull, Walter A ^a   Sheppard, Lianne ^a   Bowen, James D ^b   McCormick, Wayne C ^b   Teri, Linda ^b   Pfanschmidt, Meredith ^b   Thompson, Jill D ^b   Schellenberg, Gerard D ^b,c   Larson, Eric B ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Apolipoproteins E; Dementia; Genotype; Head injuries

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENOTYPE; HEAD INJURY; HEALTH MAINTENANCE ORGANIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; SEX DIFFERENCE; STATISTICAL ANALYSIS;

EID: 8544232115     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009290     Document Type: Article

References (63)

1. Heyman A, Wilkinson WE, Stafford JA, et al. Alzheimer's disease: a study of epidemiological aspects. Ann Neurol 1984; 15:335-41.
2. Mortimer JA, French LR, Hutton JT, et al. Head trauma as a risk factor for Alzheimer's disease. Neurology 1985;35: 264-7.
3. Amaducci LA, Fratiglioni L, Rocca WA, et al. Risk factors for clinically diagnosed Alzheimer's disease: a case-control study of an Italian population. Neurology 1986;36:922-31.
4. Shalat SL, Seltzer B, Pidcock C, et al. Risk factors for Alzheimer's disease: a case-control study. Neurology 1987;37: 1630-3.
5. Chandra V, Phillipose V, Bell PA, et al. Case-control study of late onset "probable Alzheimer's disease." Neurology 1987; 37:1295-300.
6. Chandra V, Kokmen E, Schoenberg BS, et al. Head trauma with loss of consciousness as a risk factor for Alzheimer's disease. Neurology 1989;39:1576-8.
7. Broe GA, Henderson AS, Creasey H, et al. A case-control study of Alzheimer's disease in Australia. Neurology 1990; 40:1698-707.
8. Graves AB, White E, Koepsell TD, et al. The association between head trauma and Alzheimer's disease. Am J Epidemiol 1990;131:491-501.
9. Paschalis C, Polychronopoulos P, Lekka NP, et al. The role of head injury, surgical anaesthesia and family history as aetiological factors in dementia of Alzheimer type: a prospective study. Dementia 1990;1:52-5.
10. van Duijn CM, Tanja TA, Haaxma R, et al. Head trauma and the risk of Alzheimer's disease. Am J Epidemiol 1992;135: 775-82.
11. Mayeux R, Ottman R, Tang M-X, et al. Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community-dwelling elderly persons and their first-degree relatives. Ann Neurol 1993;33:494-501.
12. Rasmusson DX, Brandt J, Martin DB, et al. Head injury as a risk factor in Alzheimer's disease. Brain Inj 1995;9:213-19.
13. Soininen H, Heinonen OP. Clinical and etiological aspects of senile dementia. Eur Neurol 1982;21:401-10.
14. Fratiglioni L, Ahlbom A, Viitanen M, et al. Risk factors for late-onset Alzheimer's disease: a population based, case-control study. Ann Neurol 1993;33:258-66.
15. Williams DB, Annegers JF, Kokmen E, et al. Brain injury and neurologic sequelae: a cohort study of dementia, parkinsonism, and amyotrophic lateral sclerosis. Neurology 1991;41: 1554-7.
16. Corsellis JA, Bruton CJ, Freeman-Browne D. The aftermath of boxing. Psychol Med 1973;3:270-303.
17. Roberts GW, Allsop D, Bruton C. The occult aftermath of boxing. J Neurol Neurosurg Psychiatry 1990;53:373-8.
18. Roberts GW, Gentleman SM, Lynch A, et al. Beta A4 amyloid protein deposition in brain after head trauma. Lancet 1991; 338:1422-3.
19. Huber A, Gabbert K, Kelemen J, et al. Density of amyloid plaques in brains after head trauma. J Neurotrauma 1993; 10(suppl):S180.
20. Roberts GW, Gentleman SM, Lynch A, et al. Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. J Neurol Neurosurg Psychiatry 1994;57:419-25.
21. Graham DI, Gentleman SM, Lynch A, et al. Distribution of beta-amyloid protein in the brain following severe head injury. Neuropathol Appl Neurobiol 1995;21:27-34.
22. McGeer PL, Rogers J. Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease. Neurology 1992;42: 447-9.
23. Kalaria RN. The immunopathology of Alzheimer's disease and some related disorders. Brain Pathol 1993;3:333-47.
24. Gordon MN. Microglia and immune activation in Alzheimer's disease. J Fla Med Assoc 1993;80:267-70.
25. Breitner JC, Gau BA, Welsh KA, et al. Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology 1994;44:227-32.
26. Rogers J, Kirby LC, Hempelman SR, et al. Clinical trial of indomethacin in Alzheimer's disease. Neurology 1993;43: 1609-11.
27. Breitner JC, Welsh KA, Helms MJ. et al. Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiol Aging 1995;16: 523-30.
28. McGeer PL, Rogers J, McGeer EG. Neuroimmune mechanisms in Alzheimer's disease pathogenesis. Alzheimer Dis Assoc Disord 1994;8:149-58.
29. Houlston RS, Snowden C, Green F, et al. Apolipoprotein (apo) E genotypes by polymerase chain reaction and allele-specific oligonucleotide probes: no detectable linkage disequilibrium between Apo E and Apo CII. Hum Genet 1989;83:364-8.
30. Strittmatter WJ, Weisgraber KH, Huang DY, et al. Binding of human apolipoprotein E to synthetic amyloid (beta) peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci U S A 1993;90:8098-102.
31. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-3.
32. Mayeux R, Stern Y, Ottman R, et al. The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease. Ann Neurol 1993;34:752-4.
33. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43: 1467-72.
34. Tsai MS, Tangalos EG, Petersen RC, et al. Apolipoprotein E: risk factor for Alzheimer's disease. Am J Hum Genet 1994; 54:643-9.
35. Saunders AM, Schmader K, Breitner JC, et al. Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid forming diseases. Lancet 1993;342: 710-1.
36. Poirier J, Davignon J, Bouthillier D, et al. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993;342: 697-9.
37. Ueki A, Kawano M, Namba Y, et al. A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late onset nonfamilial Alzheimer's disease. Neurosci Lett 1993; 163:166-8.
38. Brousseau T, Legrain S, Berr C, et al. Confirmation of the epsilon 4 allele of the apolipoprotein E gene as a risk factor for late onset Alzheimer's disease. Neurology 1994;44:342-4.
39. Peacock ML, Fink JK. Apo E epsilon 4 allelic association with Alzheimer's disease: independent confirmation using denaturing gradient gelectrophoresis. Neurology 1994;44:339-41.
40. van Duijn CM, de Knijff P, Cruts M, et al. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet 1994;7:74-8.
41. Yu CE, Payami H, Olson JM, et al. The apolipoprotein E/CI/ CII gene cluster and late-onsel Alzheimer disease. Am J Hum Genet 1994;54:631-42.
42. Nathan BP, Bellosta S, Sanan DA. Differential effecis of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 1994;264:850-2.
43. Strittmatter WJ, Weisgraber KH, Goedert M, et al. Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp Neurol 1994;125:163-71.
44. Namba Y, Tomonaga M, Kawasaki H, et al. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 1991;541:163-6.
45. Han SH, Hulette C, Saunders AM, et al. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls. Exp Neurol 1994;128:13-26.
46. Wisniewski T, Golabek A, Matsubara E, et al. Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid. Biochem Biophys Res Commun 1993;192:359-65.
47. Ma J, Yee A, Brewer HB Jr, et al. Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature 1994;372:92-4.
48. Wisniewski T, Castano EM, Golabek A, et al. Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am J Pathol 1994;145:1030-5.
49. Strittmatter WJ, Saunders AM, Goedert M, et al. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. Proc Natl Acad Sci U S A 1994;91:11183-6.
50. Mayeux R, Ottman R, Maestre G. et al. Synergistic effects of traumatic head injury and apolipoprotein-∈4 in patients with Alzheimer's disease. Neurology 1995;45:555-7.
51. Barnhart RL, van Belle G, Edland SD, et al. Geographically overlapping Alzheimer's disease registries: comparisons and implications. J Geriatr Psychiatry Neurol 1995;8:203-8.
52. McCormick WC, Kukull WA, van Belle G, et al. Symptom patterns and comorbidity in the early stages of Alzheimer's disease. J Am Geriatr Soc 1994;42:517-21.
53. Larson EB, Kukull WA, Teri L, et al. University of Washington Alzheimer's Disease Patient Registry (ADPR): 1987-1988. Aging (Milano) 1990;2:404-8.
54. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. revised. Washington, DC: American Psychiatric Association, 1987.
55. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS/ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44.
56. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
57. Fleiss JL. Statistical Methods for Rates and Proportions. New York NY: John Wiley and Sons, Inc, 1973.
58. Armstrong BK, White E, Saracci R. Principles of exposure measurement in epidemiology. New York, NY: Oxford University Press, 1992.
59. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990;31:545-8.
60. Schlesselman JJ. Case-control studies: design, conduct, analysis. New York. NY: Oxford University Press, 1982.
61. Breslow NE, Day NE. Statistical methods in cancer research. Vol 1. The analysis of case-control studies. Lyon, France: International Agency for Research on Cancer, 1980. (IARC Scientific Publication no. 32).
62. Hosmer DW, Lemeshow S. Applied logistic regression. New York, NY: John Wiley and Sons, Inc, 1989.
63. Nelson LM, Longstreth WT Jr, Koepsell TD, et al. Proxy respondents in epidemiologic research. Epidemiol Rev 1990; 12:71-86.